Literature DB >> 15931223

SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells.

Christopher S Sullivan1, Adam T Grundhoff, Satvir Tevethia, James M Pipas, Don Ganem.   

Abstract

MicroRNAs (miRNAs) are small (approximately 22-nucleotide) RNAs that in lower organisms serve important regulatory roles in development and gene expression, typically by forming imperfect duplexes with target messenger RNAs. miRNAs have also been described in mammalian cells and in infections with Epstein-Barr virus (EBV), but the function of most of them is unknown. Although one EBV miRNA probably altered the processing of a viral mRNA, the regulatory significance of this event is uncertain, because other transcripts exist that can supply the targeted function. Here we report the identification of miRNAs encoded by simian virus 40 (SV40) and define their functional significance for viral infection. SVmiRNAs accumulate at late times in infection, are perfectly complementary to early viral mRNAs, and target those mRNAs for cleavage. This reduces the expression of viral T antigens but does not reduce the yield of infectious virus relative to that generated by a mutant lacking SVmiRNAs. However, wild-type SV40-infected cells are less sensitive than the mutant to lysis by cytotoxic T cells, and trigger less cytokine production by such cells. Thus, viral evolution has taken advantage of the miRNA pathway to generate effectors that enhance the probability of successful infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15931223     DOI: 10.1038/nature03576

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  271 in total

1.  Directed Nucleosome Sliding during the Formation of the Simian Virus 40 Particle Exposes DNA Sequences Required for Early Transcription.

Authors:  Meera Ajeet Kumar; Karine Kasti; Lata Balakrishnan; Barry Milavetz
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 2.  Virus-encoded microRNAs.

Authors:  Adam Grundhoff; Christopher S Sullivan
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

3.  BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.

Authors:  Song Hee Lee; Robert F Kalejta; Julie Kerry; Oliver John Semmes; Christine M O'Connor; Zia Khan; Benjamin A Garcia; Thomas Shenk; Eain Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

Review 4.  Noncoding RNPs of viral origin.

Authors:  Joan Steitz; Sumit Borah; Demian Cazalla; Victor Fok; Robin Lytle; Rachel Mitton-Fry; Kasandra Riley; Tasleem Samji
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 5.  RNA-based antiviral immunity.

Authors:  Shou-Wei Ding
Journal:  Nat Rev Immunol       Date:  2010-08-13       Impact factor: 53.106

6.  Engineered RNA viral synthesis of microRNAs.

Authors:  Andrew Varble; Mark A Chua; Jasmine T Perez; Balaji Manicassamy; Adolfo García-Sastre; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 7.  Viral miRNAs: tools for immune evasion.

Authors:  Isaac W Boss; Rolf Renne
Journal:  Curr Opin Microbiol       Date:  2010-06-25       Impact factor: 7.934

Review 8.  Biological functions of microRNAs: a review.

Authors:  Yong Huang; Xing Jia Shen; Quan Zou; Sheng Peng Wang; Shun Ming Tang; Guo Zheng Zhang
Journal:  J Physiol Biochem       Date:  2010-10-28       Impact factor: 4.158

9.  RNA virus microRNA that mimics a B-cell oncomiR.

Authors:  Rodney P Kincaid; James M Burke; Christopher S Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 10.  Dicer's role as an antiviral: still an enigma.

Authors:  Christopher R MacKay; Jennifer P Wang; Evelyn A Kurt-Jones
Journal:  Curr Opin Immunol       Date:  2013-11-22       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.